Babylon Health: from $4.2 billion SPAC to administration in under two years
Babylon offered video GP consultations and an AI symptom checker, including through an NHS partnership. It listed in New York via SPAC at $4.2 billion and expanded into US contracts where it bore the financial risk of patients' care. Losses mounted, and it collapsed in 2023.
- Primary cause: Broken unit economics
- Scaled too early
- Lost customer trust
- Founded
- 2013
- Ended
- 2023
- Headquarters
- United Kingdom
- Sector
- Health
- Capital raised
- $600M+ before its SPAC
- Peak valuation
- $4.2B (2021 SPAC)
What happened
Its US business went bankrupt and its UK operations entered administration in August 2023; the UK business was sold to eMed.
What Babylon Health was
Ali Parsa founded Babylon in London in 2013. Its GP at Hand service let NHS patients register for virtual appointments, and its chatbot was promoted as able to assess symptoms.
Babylon went public via a SPAC in 2021. It grew in the US through value-based care contracts, taking responsibility for patients' total medical costs. As losses grew it couldn't raise more capital, and in August 2023 its businesses entered bankruptcy and administration.
Why it failed
- 1
Taking on risk it couldn't manage
Under value-based contracts, Babylon received a fixed amount per patient and paid for their care. When medical costs exceeded those payments, losses grew with every patient enrolled.
- 2
Growth that deepened losses
Adding patients under loss-making contracts grew revenue and losses together — a pattern a SPAC-funded public company struggled to finance.
- 3
Credibility questions over the AI
Clinicians publicly questioned claims about the chatbot's accuracy, raising doubts about the technology at the centre of Babylon's story.
The product lesson
Revenue growth means nothing if each new customer adds losses. In healthcare especially, understand the actuarial risk you're taking on before you scale it. Companies that succeed in value-based care usually build strong care-management capabilities before accepting full financial risk.
Early warning sign to watch for
Revenue grows quickly, but cost per patient rises faster and the company keeps signing risk-bearing contracts.
Compiled from public reporting, court records, and company statements. Figures are approximate. Where legal proceedings are mentioned, convictions are described as convictions and charges as allegations. Corrections welcome at hello@productmanagement.space.
Failed for similar reasons
- 2018–2024 · Commerce & DeliveryCazooUK online used-car retailer that delivered cars to customers' doorsRead →
- 2010–2023 · Real Estate & ConstructionWeWorkFlexible office space provider valued at $47B as a 'tech company'Read →
- 2015–2021 · Real Estate & ConstructionKaterraSoftBank-backed startup that tried to vertically integrate constructionRead →